GlaxoSmithKline Consumer Healthcare Q3 '05 PAT up 34%, Gurgaon, Oct , 2005

GlaxoSmithKline Consumer Healthcare Q3 '05 PAT up by 34 % Gurgaon, October 21, 2005: GlaxoSmithKline Consumer Healthcare Limited (GSKCH), a global nutritional healthcare company present in India since 1958, today declared its financial results for quarter ended September 30, 2005. Sales stood at Rs. 290.6 crores for the quarter, representing growth of 9.1 %. For the quarter, PAT rose 34 % to Rs. 30.3 crores and PBT grew 27.7 % to Rs. 46.5 crores. "The increase in PAT has been driven by a strong sales performance supported by the company's comprehensive cost containment programme", said Nick Massey, Managing Director, GlaxoSmithKline Consumer Healthcare Ltd. "Our focus on consumer-centric innovation is doing well. The recent launch of new Horlicks Lite has been the first of its kind in India. This launch offers the consumers two products; a health drink and a biscuit. Both of these combine great taste with the goodness of a special formulation to meet the dietary needs of health conscious adults." The company also declared an interim dividend of 80 %. For the nine months ended September 30, 2005, sales stood at Rs. 820.6 crores, 10.6 % over last year. For this period, PBT stood at Rs. 128.1 crores and PAT at Rs. 85.7 crores, 33.4 % and 41.3 % over 2004 levels. _________________________________________________________________________

About GlaxoSmithKline Consumer Healthcare Ltd. GSKCH, which was established in 1958, is an associate of GlaxoSmithKline plc. of the U.K, a global science based healthcare company. GSKCH has continually benefited from the technical and marketing inputs that have been available as a consequence of this association. GSKCH is one of the largest players in the health food drinks industry. The Company with its manufacturing plants located in Nabha, Rajahmundry and Sonepat has a total workforce of about 2700 people. GSKCH has a strong marketing and distribution network in India comprising over 1800 wholesalers and direct coverage of over 4,50,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent household names such as Eno, Crocin and Iodex.

GSKCH has a strong marketing and distribution network in India comprising over 1800 wholesalers and direct coverage of over 4,50,000 retail outlets. Its flagship product, Horlicks, is a widely regarded and highly respected brand for over 100 years. The Company also manufactures and markets Boost, Viva and Maltova and in addition markets and distributes a number of products in diverse categories, which include prominent household names such as Eno, Crocin and Iodex.